ARCHIVES

NCI Considers Making Prevention Trial From NSABP; Other Groups Approached

This article is from The Cancer Letter archive.

Vol. 20 No. 19 | May 13, 1994

Download PDF Visit The Full Archive

Related Articles

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

In Brief: Benjamin Neel named director of NYU Cancer Center

October 24, 2014

In Brief: Shannn Award Selections Made; ACS Funds 431 Grants Worth $50 Mil.; 500 Nurses Pass Exam

August 30, 1991

Research teams link response to Iressa to mutations in EGF receptor.

April 30, 2004

NIH Challenge Grant Announcement

March 6, 2009

When Screening Mammography Meets Health Care Reform, Opinions Proliferate

February 4, 1994